索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]甘振邦,魏佳展,严雪娇,等.肥厚型心肌病合并急性心肌梗死的研究进展[J].国际心血管病杂志,2023,04:213-215，220.
点击复制

肥厚型心肌病合并急性心肌梗死的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年04期
页码:
213-215，220
栏目:
综述
出版日期:
2023-07-30

文章信息/Info

Title:
-
作者:
甘振邦; 魏佳展; 严雪娇; 葛继勇
233030 蚌埠医学院研究生院（甘振邦，魏佳展）；213000 南京医科大学附属常州市第二人民医院心血管内科（严雪娇，葛继勇）通信作者：葛继勇， E-mail：jiyong_ge@163.com
Author(s):
-
关键词:
肥厚型心肌病; 急性心肌梗死; 临床特点; 预后
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.04.006
文献标识码:
-
摘要:
肥厚型心肌病为常见的常染色体显性遗传性心肌病，可增加急性心肌梗死患者死亡的风险。该文介绍肥厚型心肌病合并急性心肌梗死的危险因素、临床特点和预后。
Abstract:
-

参考文献/References

[1]Ong KC, Geske JB, Hebl VB, et al. Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6):604-610.
[2] 曹博涵, 吴光哲. 肥厚型心肌病研究进展[J]. 临床军医杂志, 2020, 48(4):469-471.
[3] 惠汝太. 攻克肥厚型心肌病:曙光初现任重道远[J]. 中华心血管病杂志, 2017, 45(12):1008-1011.
[4]Spirito P, Autore C, Formisano F, et al. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors[J]. Am J Cardiol, 2014, 113(9):1550-1555.
[5]Veselka J, Zemánek D, Jahnlová D, et al. Risk and causes of death in patients after alcohol septal ablation for hypertrophic obstructive cardiomyopathy[J]. Can J Cardiol, 2015, 31(10):1245-1251.
[6]Maron BJ, Rowin EJ, Casey SA, et al. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies[J]. J Am Coll Cardiol, 2015, 65(18):1915-1928.
[7]Maron BJ, Ommen SR, Semsarian C, et al. Hypertrophic cardiomyopathy:present and future,with translation into contemporary cardiovascular medicine[J]. J Am Coll Cardiol, 2014, 64(1):83-99.
[8]Gupta T, Harikrishnan P, Kolte D, et al. Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy[J]. Am J Med, 2015, 128(8):879-887.
[9] 刘培光, 赵红, 刘艳军, 等. 肥厚型梗阻性心肌病快速心房扑动诱发急性心肌梗死1例[J]. 国际心血管病杂志, 2015,42(6):435-436.
[10] Ho CY, Charron P, Richard P, et al. Genetic advances in sarcomeric cardiomyopathies:state of the art[J]. Cardiovasc Res, 2015, 105(4):397-408.
[11] Kimura A. Molecular genetics and pathogenesis of cardiomyopathy[J]. J Hum Genet, 2016, 61(1):41-50.
[12] Veselka J, Anavekar NS, Charron P. Hypertrophic obstructive cardiomyopathy[J]. Lancet, 2017, 389(10075):1253-1267.
[13] Lv S, Liu W, Zhou Y, et al. Hyperuricemia and severity of coronary artery disease: an observational study in adults 35 years of age and younger with acutecoronary syndrome[J]. Cardiol J, 2019, 26(3):275-282.
[14] Liu F, Ma Y, Ge H, et al. Long-term outcomes of acute myocardial infarctionin patients with hypertrophic cardiomyopathy[J]. Angiology, 2018, 69(10):900-908.
[15] 马越, 刘放, 张黛, 等. 急性心肌梗死合并肥厚型心肌病患者临床特征和远期预后及危险因素分析[J]. 中国医药, 2018, 13(12):1761-1765.
[16] Marian AJ, Braunwald E. Hypertrophic cardiomyopathy:genetics, pathogenesis, clinical manifestations, diagnosis, and therapy[J]. Circ Res, 2017, 121(7):749-770.
[17] Shin YJ, Lee JH, Yoo JY, et al. Clinical significance of evaluating coronary atherosclerosis in adult patients with hypertrophic cardiomyopathy who have chest pain[J]. Eur Radiol, 2019, 29(9):4593-4602.
[18] Parr CJ, Sharma R, Garber PJ. Apical hypertrophic cardiomyopathy treated as ST-elevation myocardial infarction[J]. CJEM, 2018, 20(S2):S51-S55.
[19] 林晨, 陈梓娴, 向晓睿, 等. 急性心肌梗死磁共振研究进展[J]. 磁共振成像, 2021, 12(1):106-108.
[20] Yang YJ, Fan CM, Yuan JQ, et al. Long-term survival after acute myocardial infarction in patients with hypertrophic cardiomyopathy[J]. Clin Cardiol, 2017, 40(1):26-31.
[21] Wu VCC, Chen TH, Wu M, et al. Outcomes of patients with hypertrophic cardiomyopathy and acute myocardial infarction: a propensity score-matched, 15-year nationwide population-based study in Asia[J]. BMJ Open, 2018, 8(8):e019741.
[22] Smilowitz NR, Mahajan AM, Roe MT, et al. Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION Registry-GWTG (acute coronary treatment and intervention outcomes network registry-get with the guidelines)[J]. Circ Cardiovasc Qual Outcomes, 2017, 10(12):e003443.
[23] Wang Y, Zhao X, Zhai M, et al. Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?[J]. BMC Cardiovasc Disord, 2022, 22(1):168.
[24] Tuohy CV, Kaul S, Song HK, et al. Hypertrophic cardiomyopathy: the future of treatment[J]. Eur J Heart Fail, 2020, 22(2):228-240.
[25] Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction[J]. Lancet, 2017, 389(10065):197-210.
[26] Wu J, Hall M, Dondo TB, et al. Association between time of hospitalization with acute myocardial infarction and in-hospital mortality[J]. Eur Heart J, 2019, 40(15):1214-1221.
[27] 刘杰, 刘文玲, 胡大一, 等. 中国大样本队列肥厚型心肌病患者基因突变谱及其临床相关性[J]. 中华心血管病杂志, 2015, 43(8):682-689.
[28] 邓清文, 何森. 肥厚型心肌病合并心房颤动的研究进展[J].心血管病学进展, 2021, 42(4):327-331.
[29] Maron BJ, Rowin EJ, Udelson JE, et al. Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy[J]. JACC Heart Fail, 2018, 6(5):353-363.
[30] White SK, Frohlich GM, Sado DM, et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-Segment elevation myocardial infarction[J]. JACC Cardiovasc Interv, 2015, 8(1):178-188.
[31] Donato M, Bin EP, D Annunzio V, et al. Myocardial remote ischemic preconditioning: from cell biology to clinical application[J]. Mol Cell Biochem, 2021, 476(10):3857-3867.
[32] Aguiar Rosa S, Rocha Lopes L, Fiarresga A, et al. Coronary microvascular dysfunction in hypertrophic cardiomyopathy:pathophysiology, assessment, and clinical impact[J]. Microcirculation, 2021, 28(1):e12656.
[33] Yang JQ, Wang LS, Sun TN, et al. Obesity is associated with worse long-term outcomes in hypertrophic cardiomyopathy patients with acute myocardial infarction[J]. Perfusion, 2020, 35(5):384-392.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（81900453）；南京医科大学基金重点项目（2017NJMUZD038）
（收稿：2022-07-17 修回：2023-04-25）
更新日期/Last Update: 2023-08-01